⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

Over $1M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying

Published 30/01/2024, 11:52
© Reuters.  Over $1M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
KALV
-
FBK
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Although U.S. stocks closed higher on Monday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

KalVista Pharmaceuticals

  • The Trade: KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) 10% owner Nimish Shah acquired a total of 91,804 shares an average price of $14.05. To acquire these shares, it cost around $1.29 million.
  • What’s Happening: KalVista Pharma, last month, announced publication of first oral factor XIIa data in Frontiers in Pharmacology.
  • What KalVista Pharmaceuticals Does: KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases.
Nuveen Churchill Direct Lending
  • The Trade: Nuveen Churchill Direct Lending Corp. (NYSE: NCDL) 10% owner America of Association Annuity Insurance Teachers acquired a total of 1,662,050 shares at an average price of $18.05. To acquire these shares, it cost around $30 million.
  • What’s Happening: The company recently priced its IPO at $18.05 per share.
  • What Nuveen Churchill Direct Lending Does: Nuveen Churchill Direct Lending Corp is a specialty finance company focused primarily on investing in senior secured loans to private equity-owned U.S. middle market companies.
Don’t forget to check out our premarket coverage here

FB Financial

  • The Trade: FB Financial Corporation (NYSE: FBK) Director Raja Jubran bought a total of 14,808 shares at an average price of $26.97. To acquire these shares, it cost around $399,416.
  • What’s Happening: Hovde Group analyst Brett Rabatin recently downgraded FB Financial from Outperform to Market Perform and announced a $40 price target.
  • What FB Financial Does: FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia.

Check This Out: Alphabet, Microsoft And 3 Stocks To Watch Heading Into Tuesday

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.